Under the supervision of physicians with knowledge and experience in regenerative medicine cultivated at the Kyoto University Center for iPS Cell Research and Application (CiRA), we provide high-quality, evidence-based medical care.

Drawing on our extensive experience in home healthcare, we offer comprehensive medical care tailored to a wide range of symptoms and individual patient needs.

English-language consultation and support are available.

Eligible Conditions

Suitable for almost all types of cancer, including solid tumors and hematologic malignancies (blood cancers).
Available for patients at all stages of cancer.
Examples include:
Lung Cancer
Gastric (Stomach) Cancer
Colorectal Cancer
Liver Cancer
Pancreatic Cancer
Breast Cancer
Prostate Cancer
Uterine and Ovarian Cancers
Esophageal Cancer
Head and Neck Cancer
and many other cancer types.
Can also be provided in combination with standard cancer treatments, such as surgery, chemotherapy, radiation therapy, and targeted therapy, when clinically appropriate.

Program details

【Medical Specialty】
NKT Cell-Targeted Therapy (Cancer Immunotherapy / Cell Therapy / Regenerative Medicine)

This outpatient treatment activates the patient's own immune cells and administers them by intravenous infusion or subcutaneous injection. Treatment is performed once every two weeks for a total of four sessions. Hospitalization is not required, and the treatment is generally associated with few side effects.

【Treatment Method】
NKT Cell-Targeted Therapy (Cancer Immunotherapy / Cell Therapy / Regenerative Medicine)

Uses the patient's own immune cells after activation.
Administered by intravenous infusion or subcutaneous injection.
Outpatient day treatment.
One treatment every two weeks (4 treatments in total).
No hospitalization required.
Generally associated with minimal side effects.
Treatment Area / Organ

【Whole Body】
This therapy is not limited to a specific organ and may be used for cancers arising in almost any organ system.

【Program Overview】
NKT Cell-Targeted Therapy is an innovative form of cancer immunotherapy that artificially activates Natural Killer T (NKT) cells, which play a central role in regulating the immune system. By activating these cells, the therapy aims to modify the immune environment surrounding tumors and promote a sustained immune response against cancer cells.

The safety and clinical efficacy of this therapy have been demonstrated in clinical trials jointly conducted by Chiba University Hospital and RIKEN (The Institute of Physical and Chemical Research). More than 500 patients in Japan have already received this treatment.

At our clinic, the therapy is provided under the supervision of physicians with expertise in regenerative medicine developed through experience at the Kyoto University Center for iPS Cell Research and Application (CiRA).

The treatment is available for patients at all stages of cancer and for almost all types of cancer, and may be used alongside standard cancer treatments when clinically appropriate.

Because the therapy utilizes the patient's own immune cells, it is generally associated with very few side effects. Treatment is performed as an outpatient day procedure using intravenous infusion or subcutaneous injection, eliminating the need for hospitalization.

Providing Medical Institution

Grand Green Osaka Umekita Clinic

〒530-0011
Grand Green Osaka, South Building Gate Tower 5F, 5-54 Ofukacho, Kita-ku, Osaka Osaka

https://umekitaclinic.org/

Specialty

Cancer Immunotherapy
Regenerative Medicine
Anti-Aging Medicine and Blood Purification Therapy (including LDL Apheresis)
Aesthetic Dermatology
Aesthetic Surgery
Genomic Health Screening (Advanced health screening to detect genetic abnormalities at the genomic level)

Eligibility Criteria/Exclusions for Treatment

Eligibility Requirements
・Patients must be able to provide medical records necessary for evaluation, including their current medical history, previous treatments, examination and test results, and other information required to assess their overall health condition.
・Patients must be able to visit the clinic a total of five times:
First visit: medical consultation, examinations, and blood collection.
Subsequent visits: four treatment sessions, performed once every two weeks.

Remarks

【Treatment Schedule】
1.Initial Consultation and Blood Tests
2.Apheresis (Blood Component Collection)
Performed at least one week after the blood tests.
3.Cell Processing and Culture
The collected cells are processed and cultured at a certified cell processing facility.
4.Activation of NKT Cells
5.Outpatient Treatment Administration
Treatment is administered once every two weeks, for a total of four sessions.

Precautions / Contraindications

Treatment may not be available for patients who meet any of the following conditions:
Severe anemia
Coagulation disorders (abnormal blood clotting)
Blood-borne infectious diseases, including:
Hepatitis B virus (HBV)
Hepatitis C virus (HCV)
Human Immunodeficiency Virus (HIV/AIDS)
Syphilis